Discover

GOSS
Gossamer Bio, Inc.
9.31
1 x 10.40
1 x 11.57
bid
ask
-
0.57
5.77%
1 @ 04:00 PM
9.30 -0.01 (0.11%)
Ytd-96.25%
1y-95.45%
9.20
day range
10.10
9.31
52 week range
303.20
Open9.93Prev Close9.88Low9.20High10.10Mkt Cap56.94M
Vol291.00KAvg Vol378.37KEPS-52.80P/EN/AForward P/E-0.69
Beta2.00Short Ratio3.80Inst. Own77.48%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg12.53200-d Avg59.001yr Est132.48
Income Statement
Total Revenue9.24M
Revenues (USD)9.24M
Gross Profit9.24M
Operating Expenses35.31M
Research and Development Expense26.41M
Selling, General and Administrative Expense8.90M
Operating Income-26.07M
Interest Expense2.71M
Net Income16.90M
Net Income Common Stock16.90M
Net Income Common Stock (USD)16.90M
Consolidated Income16.90M
Earnings per Basic Share4.00
Earnings per Basic Share (USD)4.00
Earnings per Diluted Share-6.40
Earning Before Interest & Taxes (EBIT)19.61M
Earning Before Interest & Taxes (USD)19.61M
Weighted Average Shares4.00M
Weighted Average Shares Diluted4.11M
Balance Sheet
Cash and Equivalents41.15M
Cash and Equivalents (USD)41.15M
Investments15.88M
Investments Current15.88M
Trade and Non-Trade Receivables6.11M
Current Assets72.72M
Property, Plant & Equipment Net3.71M
Total Assets76.87M
Debt Current36.15M
Total Debt39.10M
Current Liabilities137.78M
Debt Non-Current2.96M
Total Liabilities170.90M
Accumulated Retained Earnings (Deficit)-1.47B
Accumulated Other Comprehensive Income-3.73M
Shareholders Equity-94.03M
Shareholders Equity (USD)-94.03M
Assets Non-Current4.14M
Total Debt (USD)39.10M
Deferred Revenue37.22M
Liabilities Non-Current33.11M
Trade and Non-Trade Payables5.95M
Cash Flow
Depreciation, Amortization & Accretion252.00K
Net Cash Flow from Financing-3.14M
Net Cash Flow / Change in Cash & Cash Equivalents120.00K
Issuance (Repayment) of Debt Securities -1.96M
Net Cash Flow from Investing42.70M
Net Cash Flow - Investment Acquisitions and Disposals42.70M
Net Cash Flow from Operations-39.42M
Effect of Exchange Rate Changes on Cash -12.00K
Share Based Compensation2.46M